Cholangiocarcinoma: Clinical Trials

12 trials for Cholangiocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 3 completed, 2 recruiting, 1 withdrawn. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Unknown 6, Completed 3, Recruiting 2, Withdrawn 1

Follow Cholangiocarcinoma: new trials by email Literature Review of Cholangiocarcinoma trials Research Report on Cholangiocarcinoma

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Olutasidenib, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and OATP1B1 Probe Substrates - AML (Acute Myeloid Leukemia), Glioma
Phase 4RecruitingRigel Pharmaceuticals162026-02-232026-08-11
Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
Lenvatinib - Intrahepatic Cholangiocarcinoma
Phase 4UnknownZhiyong Huang202024-05-302024-05-22
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Photosensitizer, Radiofrequency ablation (RFA) - Hilar Cholangiocarcinoma
Phase 4RecruitingUniversity of Leipzig2582023-02-102025-03-27
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Recombinant Human Adenovirus Type 5, HAIC of FOLFOX - Cholangiocarcinoma, Intrahepatic
Phase 4UnknownBeijing Tsinghua Chang Gung Hospital662022-08-012024-03-04
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy
Enteral nutrition, Oral nutrition - Pancreatic Cancer, Cancer of the Duodenum
Phase 4UnknownMedical University of Warsaw962016-11-012016-11-23
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Sevoflurane, Desflurane - Hepatocellular Carcinoma, Hepatoma
Phase 4WithdrawnTokyo Medical and Dental University2014-07-012023-05-03
Etomidate vs. Midazolam for Sedation During ERCP
Etomidate, Midazolam, Meperidine - Choledocholithiasis, Cholangiocarcinoma
Phase 4CompletedCheju Halla General Hospital632013-04-012015-06-29
Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture
SEMS insertion, DLS insertion - Bile Duct Obstruction, Klatskin's Tumor
Phase 4UnknownSoon Chun Hyang University1002010-05-012011-03-10
Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Preoperative biliary drainage - Cholangiocarcinoma, Drainage
Phase 4UnknownSun Yat-sen University822008-05-012008-11-25
Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
biliary stent - Unresectable Hilar Cholangiocarcinoma
Phase 4UnknownKhon Kaen University802008-01-012008-09-04
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
biliary stent (self expandable metallic stent), PS - Hilar Cholangiocarcinoma
Phase 4CompletedKhon Kaen University1082007-11-012011-12-23
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
oral nutritional supplement rich in eicosapentanoic acid - Colorectal Neoplasms, Hepatocellular Carcinoma
Phase 4CompletedCharite University, Berlin, Germany302005-01-012008-05-09

Narrower conditions

Klatskin Tumor (4)  ·  Carcinoma, Hepatocellular (2)  ·  Pancreatic Neoplasms (2)  ·  Bile Duct Neoplasms (1)  ·  Choledocholithiasis (1)  ·  Cholestasis (1)  ·  Colorectal Neoplasms (1)  ·  Duodenal Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Glioma (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasms (1)  ·  Pancreatitis (1)  ·  Pancreatitis, Chronic (1)

Broader conditions

Adenocarcinoma (12)  ·  Carcinoma (12)  ·  Neoplasms by Histologic Type (12)  ·  Neoplasms, Glandular and Epithelial (12)  ·  Neoplasms (11)  ·  Digestive System Diseases (6)  ·  Digestive System Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Biliary Tract Diseases (4)  ·  Bile Duct Diseases (3)  ·  Biliary Tract Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Gastrointestinal Diseases (2)

Interventions

Self Expandable Metallic Stents (2)  ·  Cytochrome P-450 CYP1A2 (1)  ·  Cytochrome P-450 CYP2B6 (1)  ·  Cytochrome P-450 CYP2C19 (1)  ·  Cytochrome P-450 CYP2C8 (1)  ·  Cytochrome P-450 CYP2C9 (1)  ·  Cytochrome P-450 CYP3A (1)  ·  Desflurane (1)  ·  Diet (1)  ·  Eicosapentaenoic Acid (1)  ·  Enteral Nutrition (1)  ·  Etomidate (1)  ·  Folfox protocol (1)  ·  Meperidine (1)  ·  Midazolam (1)

Sponsors

Khon Kaen University (2)  ·  Beijing Tsinghua Chang Gung Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  Cheju Halla General Hospital (1)  ·  Medical University of Warsaw (1)  ·  Rigel Pharmaceuticals (1)  ·  Soon Chun Hyang University (1)  ·  Sun Yat-sen University (1)  ·  Tokyo Medical and Dental University (1)  ·  University of Leipzig (1)  ·  Zhiyong Huang (1)

Countries

China (3)  ·  Germany (2)  ·  South Korea (2)  ·  Thailand (2)  ·  Japan (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Albrecht Hoffmeister, Prof.Dr.med. (1)  ·  Koshi Makita, M.D. (1)  ·  Lijian Liang (1)  ·  Marek Wronski, MD (1)  ·  Matthias Pirlich, MD (1)  ·  Worrarat Kongkasame, MD (1)  ·  Xiaoyu Yin, MD (1)  ·  Zhiyong Huang (1)

Results publications

PMID 12838220, PMID 22595446, PMID 40812353